z-logo
open-access-imgOpen Access
Macrofilaricidal Benzimidazole–Benzoxaborole Hybrids as an Approach to the Treatment of River Blindness: Part 1. Amide Linked Analogs
Author(s) -
Tsutomu Akama,
Yvonne R. Freund,
Pamela Berry,
David S. Carter,
Eric E. Easom,
Kurt Jarnagin,
Christopher S. Lunde,
Jacob J. Plattner,
Fernando Rock,
Rianna Stefanakis,
Chelsea Fischer,
Christina A. Bulman,
Kee Chong Lim,
Brian M. Suzuki,
Nancy Tricoche,
Abdelmoneim Mansour,
Utami DiCosty,
Scott McCall,
Ben Carson,
John W. McCall,
James H. McKerrow,
Marc P. Hübner,
Sabine Specht,
Achim Hoerauf,
Sara Lustigman,
Judy A. Sakanari,
Robert T. Jacobs
Publication year - 2019
Publication title -
acs infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.324
H-Index - 39
ISSN - 2373-8227
DOI - 10.1021/acsinfecdis.9b00396
Subject(s) - onchocerciasis , onchocerca volvulus , benzimidazole , brugia malayi , pharmacology , brugia pahangi , ivermectin , filariasis , in vivo , wuchereria bancrofti , blindness , oral administration , biology , chemistry , medicine , helminths , immunology , microbiology and biotechnology , ecology , organic chemistry , optometry
A series of benzimidazole-benzoxaborole hybrid molecules linked via an amide linker are described that exhibit good in vitro activity against Onchocerca volvulus , a filarial nematode responsible for the disease onchocerciasis, also known as river blindness. The lead identified in this series, 8a  (AN8799), was found to have acceptable pharmacokinetic properties to enable evaluation in animal models of human filariasis. Compound 8a was effective in killing Brugia malayi , B. pahangi , and Litomosoides sigmodontis worms present in Mongolian gerbils when dosed subcutaneously as a suspension at 100 mg/kg/day for 14 days but not when dosed orally at 100 mg/kg/day for 28 days. The measurement of plasma levels of 8a at the end of the dosing period and at the time of sacrifice revealed an interesting dependence of activity on the extended exposure for both 8a and the positive control, flubendazole.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom